Parliament
Get active in drug policy
Hot topics: alcohol, drug law review, and tobacco. The Government and its agencies, Parliament and other organisations often seek comment and input into drug policy issues. This might be in the form of consultations or inviting submissions to select committees, or seeking expert comment on draft policies.
Misuse of Drugs (Classification of BZP) Amendment Bill (Submission)
This submission sets out what we believe can reasonably be concluded from current evidence about BZP and its harms, then analyses the potential impacts of the Bill. In developing this submission, we have consulted with a number of people and organisations within the alcohol and drug sector. We have also reviewed research findings on BZP. Our comments are influenced by the Drug Foundation’s guiding principles, including evidence based best practice and policy, and harm minimisation.
10 May 2007 | Reducing drug demand a good investment
The Drug Foundation welcomed the Government’s increased investment in reducing demand for drugs, released today in a pre-budget announcement.
Reclassification of bzp (Submission)
In 2004 Mr Anderton asked the Expert Advisory Committee on Drugs (EACD) to review recent New Zealand research on benzylpiperazine (BZP), the main ingredient in most party pills. The official EACD report was released by Mr Anderton on 20 December 2006. It recommended BZP be classified as C1 under the Misuse of Drugs Act alongside drugs such as cannabis. It is illegal to possess or sell Class C drugs.
National drug policy
The National Drug Policy (NDP) aims to improve the health and wellbeing of New Zealanders by encouraging the development of strategies and programmes which prevent and reduce drug-related harm.The NDP is in line with World Health Organization and United Nations recommendations of a balanced approach to drug policy.Progress under the NDP is reviewed twice yearly by the Ministerial Committee on Drug Policy (MCDP). Initiatives are progressed and monitored by a group of Government agencies that make up the Inter-Agency Committee on Drugs (IACD).
National alcohol strategy 2000-2003
In a formal sense, the National Alcohol Strategy sits under the New Zealand Health Strategy and the National Drug Policy. The New Zealand Health Strategy sets the platform for change and identifies key priority areas, the National Drug Policy sets out the Government's commitment to minimise all drug related harm; and identifies various priority areas and desired outcomes towards this end.
Seeing through the smoke: tobacco monitoring in New Zealand 2005
This report extends the brief section on monitoring included in Clearing the Smoke, the Ministry of Health's five-year strategic plan for tobacco control (2004-2009), and provides a more detailed overview of the current state of tobacco monitoring in New Zealand.
Clearing the smoke: A five-year plan for tobacco control in New Zealand 2004–2009
This document details how the Ministry of Health plans to progress tobacco control activities over the five-year period 2004.2009. It has been developed from a literature review updating the evidence for major tobacco control interventions (Wilson 2003). It has taken into account previous planning in New Zealand and overseas, as well as feedback from consultation.
